Cytoplasmic expression of laminin-5γ2 chain is associated with progression and acquisition of malignant traits in ovarian serous and mucinous tumors
Authors:
- Yosuke TajikaYTYosuke Tajika
- Johji ImuraJIJohji Imura
- Akira NoguchiANAkira Noguchi
- Megumi OritaMOMegumi Orita
- Yuki NakajimaYNYuki Nakajima
- Takashi MinamisakaTMTakashi Minamisaka
- Kohji TakagiKTKohji Takagi
- Tomoko ShimaTSTomoko Shima
- Akitoshi NakashimaANAkitoshi Nakashima
- Kenichi HirabayashiKHKenichi Hirabayashi
Open Access
- 12 June 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (24) , e49220
Abstract
Ovarian tumors are classified into adenoma, borderline tumor, and adenocarcinoma based on cellular atypia and invasion. However, invasion can be difficult to assess histologically, underscoring the need for objective biomarkers. Laminin-5γ2 chain (Lam5γ2), a component of the basement membrane, has been implicated in tumor cell invasion in various malignancies. This study aimed to investigate the immunohistochemical expression of Lam5γ2 as a potential adjunctive biomarker associated with invasive phenotypes in ovarian serous and mucinous tumors. Lam5γ2 immunohistochemistry was performed on 80 ovarian tumor specimens, including adenomas, borderline tumors, and adenocarcinomas of serous and mucinous subtypes. Lam5γ2 expression patterns were compared across histological categories. In serous tumors, Lam5γ2 expression along the basement membrane was preserved in approximately half of adenomas and borderline tumors but was absent in all adenocarcinomas. Notably, cytoplasmic expression was observed in 11 of 12 serous adenocarcinomas (92%), and cytoplasmic staining was more frequent in borderline tumors and adenocarcinomas than in adenomas. A similar pattern was observed in mucinous tumors, with a decrease in basement membrane expression from adenomas to borderline tumors to adenocarcinomas. In mucinous adenocarcinomas, cytoplasmic expression was present in 6 of 10 cases, while basement membrane linear expression was retained in 3 of 10 cases. These differences were statistically significant in both serous and mucinous tumors ( P <.001 and P = .03, respectively). Loss of Lam5γ2 expression from the basement membrane and aberrant cytoplasmic localization in ovarian serous and mucinous tumor cells were associated with histological progression and invasive phenotypes. Thus, Lam5γ2 immunoreactivity may serve as a potential adjunctive biomarker, particularly in diagnostically challenging borderline or microinvasive cases, pending validation in larger, independent cohorts.Keywords
This publication has 27 references indexed in Scilit:
- The α3 laminin subunit, α6β4 and α3β1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skinJournal of Cell Science, 1999
- Expression of the laminin ?2 chain in different histological types of lung carcinoma. A study by immunohistochemistry andin situ hybridizationThe Journal of Pathology, 1999
- Wide Distribution of Laminin-5 γ2 Chain in Basement Membranes of Various Human TissuesHormone Research in Paediatrics, 1998
- Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasiaThe Journal of Pathology, 1998
- Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5Science, 1997
- Differential expression of laminin 5 (alpha 3 beta 3 gamma 2) by human malignant and normal prostate.1996
- Laminin 5 Deposition Promotes Keratinocyte MotilityExperimental Cell Research, 1996
- Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas.1995
- A new nomenclature for the lamininsMatrix Biology, 1994
- Formation of hemidesmosomes in cells of a transformed murine mammary tumor cell line and mechanisms involved in adherence of these cells to laminin and kalininJournal of Cell Science, 1993